Answer Questions for Patients Switching to a Biosimilar

More questions will come up about biosimilars...now that BC will require patients to switch to biosimilars to save healthcare dollars.

Biosimilars are biologics that are highly SIMILAR to the original, or "reference," biologic...but cost up to 50% less.

For example, patients in BC may be switched from Lantus to Basaglar (insulin glargine)...Enbrel to Brenzys or Erelzi (etanercept)...or Remicade to Inflectra or Renflexis (infliximab).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote